<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66395</article-id><article-id pub-id-type="doi">10.7554/eLife.66395</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-220494"><name><surname>Cheng</surname><given-names>Shuhua</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220495"><name><surname>Zhang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183164"><name><surname>Inghirami</surname><given-names>Giorgio</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-220496"><name><surname>Tam</surname><given-names>Wayne</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4283-0005</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Weill Cornell Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-20976"><name><surname>Olszewski</surname><given-names>Adam</given-names></name><role>Reviewing editor</role><aff><institution>Brown University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>wtam@med.cornell.edu</email> (WT);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>09</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e66395</elocation-id><history><date date-type="received"><day>11</day><month>01</month><year>2021</year></date><date date-type="accepted"><day>13</day><month>09</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Cheng et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Cheng et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66395-v1.pdf"/><abstract><sec><title>Background:</title><p>Although advance has been made in understanding the pathogenesis of mature T-cell neoplasms, the initiation and progression of angioimmunoblastic T cell lymphoma (AITL) and peripheral T cell lymphoma, not otherwise specified (PTCL-NOS), remains poorly understood. A subset of AITL/PTCL-NOS patients develop concomitant hematologic neoplasms (CHN), and a biomarker to predict this risk is lacking. </p></sec><sec><title>Methods:</title><p>We generated and analyzed the mutation profiles through 537-gene targeted sequencing of the primary tumors and matched bone marrow/peripheral blood samples in 25 patients with AITL and 2 with PTCL-NOS. </p></sec><sec><title>Results:</title><p>Clonal hematopoiesis (CH)-associated genomic alterations, found in 70.4% of the AITL/PTCL-NOS patients, were shared among CH and T-cell lymphoma, as well as concomitant myeloid neoplasms or diffuse large B-cell lymphoma (DLBCL) that developed before or after AITL. Aberrant AID/APOBEC activity-associated and tobacco smoking-associated mutational signatures were respectively enriched in the early CH-associated mutations and late non-CH associated mutations during AITL/PTCL-NOS development. Moreover, analysis showed that the presence of CH harboring ≥ 2 pathogenic TET2 variants with ≥ 15% of allele burden conferred higher risk for CHN (P = 0.0006, hazard ratio = 14.01, PPV=88.9%, NPV=92.1%). </p></sec><sec><title>Conclusion:</title><p>We provided genetic evidence that AITL/PTCL-NOS, CH, CHN can frequently arise from common mutated hematopoietic precursor clones. Our data also suggests smoking exposure as a potential risk factor for AITL/PTCL-NOS progression. These findings provide insights into the cell origin and etiology of AITL and PTCL-NOS and provide a novel stratification biomarker for CHN risk in AITL patients. </p></sec><sec><title>Funding:</title><p>R01 grant (CA194547) from the National Cancer Institute to WT.</p></sec></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01 CA194547</award-id><principal-award-recipient><name><surname>Tam</surname><given-names>Wayne</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This study was conducted in accordance with the Declaration of Helsinki regulations of the protocols approved by the Institutional Review Board of Weill Cornell Medicine, New York, USA. Written consent for use of the samples for research was obtained from patients or their guardians.(#0107004999)</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All relevant data are included in this manuscript and the supplementary files.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Lewis NE </collab><collab>Petrova-Drus K</collab><collab>Huet S</collab><collab>Epstein-Peterson ZD</collab><collab>Gao Q</collab><collab>Sigler AE</collab><collab>Baik J</collab><collab>Ozkaya N</collab><collab>Moskowitz AJ</collab><collab>Kumar A</collab><collab>Horwitz SM</collab><collab>Zhang Y </collab><collab>Arcila ME </collab><collab>Levine RL </collab><collab>Roshal M</collab><collab>Dogan A</collab><collab>Xiao W</collab></person-group><year iso-8601-date="2020">2020</year><source>Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms</source><ext-link ext-link-type="uri" xlink:href="https://ashpublications.org/bloodadvances/article/4/10/2261/456037/Clonal-hematopoiesis-in-angioimmunoblastic-T-cell">https://ashpublications.org/bloodadvances/article/4/10/2261/456037/Clonal-hematopoiesis-in-angioimmunoblastic-T-cell</ext-link><comment>Table 2 and supplmental file 1</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Watatani Y</collab><collab>Sato Y</collab><collab>Miyoshi H</collab><collab>Sakamoto K</collab><collab>Nishida K</collab><collab>Gion Y</collab><collab>Nagata Y</collab><collab>Shiraishi Y</collab><collab>Chiba K</collab><collab>Tanaka H</collab><collab>Zhao L</collab><collab>Ochi Y</collab><collab>Takeuchi Y</collab><collab>Takeda J</collab><collab>Ueno H</collab><collab>Kogure Y</collab><collab>Shiozawa Y</collab><collab>Kakiuchi N</collab><collab>Yoshizato T</collab><collab>Nakagawa MM</collab><collab>Nanya Y</collab><collab>Yoshida K</collab><collab>Makishima H</collab><collab>Sanada M</collab><collab>Sakata-Yanagimoto M</collab><collab>Chiba S</collab><collab>Matsuoka R</collab><collab>Noguchi M</collab><collab>Hiramoto N</collab><collab>Ishikawa T</collab><collab>Kitagawa J</collab><collab>Nakamura N</collab><collab>Tsurumi H</collab><collab>Miyazaki T</collab><collab>Kito Y</collab><collab>Miyano S</collab><collab>Shimoda K</collab><collab>Takeuchi K</collab><collab>Ohshima K</collab><collab>Yoshino T</collab><collab>Ogawa S</collab><collab>Kataoka K</collab></person-group><year iso-8601-date="2019">2019</year><source>Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling</source><ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/s41375-019-0473-1#Sec30">https://www.nature.com/articles/s41375-019-0473-1#Sec30</ext-link><comment>Supplemental table S9</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-66395-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>